CDT Equity Increases Bitcoin Holding

Rhea-AI Summary

CDT Equity (Nasdaq: CDT) on October 17, 2025 acquired 9.25648743 Bitcoin (BTC) for an aggregate purchase price of $1,005,000 (gross of fees) at an average price of $108,301.75 per BTC.

Following the purchase, CDT’s total Bitcoin holdings are 17.9090111 BTC. The company described the transaction as part of its cryptocurrency treasury reserve strategy to diversify the balance sheet and pursue long-term shareholder value through disciplined accumulation of digital assets.

Positive

• Added 9.25648743 BTC on October 17, 2025
• Total Bitcoin holdings increased to 17.9090111 BTC
• Deployed $1,005,000 to treasury reserve purchases

Negative

• Exposes balance sheet to Bitcoin price volatility
• Deployment of $1,005,000 reduces available cash liquidity

NAPLES, Fla. and CAMBRIDGE, United Kingdom, Oct. 17, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced the acquisition of 9.25648743 Bitcoin (“BTC”) for an aggregate purchase price of $1,005,000 (gross of fees), at an average acquisition price of $108,301.75 per BTC. Following this transaction, CDT’s total Bitcoin holdings now stand at 17.9090111 BTC.

This acquisition marks a continued execution of CDT’s cryptocurrency treasury reserve strategy, aimed at diversifying the Company’s balance sheet and enhancing long-term shareholder value through the prudent accumulation of digital assets.

“CDT remains committed to strategically deploying capital within its treasury reserve program,” said James Bligh, Chief Financial Officer of CDT. “Our Bitcoin acquisitions form part of a disciplined, opportunistic approach to capital management, designed to align with the growing institutional adoption of digital assets, capitalize on market corrections, and strengthen our overall financial resilience.”

About CDT Equity Inc.

CDT Equity Inc. (NASDAQ: CDT) is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. Originally established as Conduit Pharmaceuticals, the company has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. In parallel, CDT has implemented a cryptocurrency treasury reserve strategy, initially focused on Bitcoin (BTC), designed to diversify its capital allocation and strengthen its financial position. Looking ahead, CDT are committed to creating shareholder value through licensing, strategic M&A, and positioning the company as a platform for transformative innovation.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of the federal securities laws. All statements other than statements of historical facts contained in this press release, including statements regarding CDT's future results of operations and financial position, CDT's business strategy, prospective product candidates, product approvals, research and development costs, timing and likelihood of success, plans and objectives of management for future operations, future results of current and anticipated studies and business endeavors with third parties, and future results of current and anticipated product candidates, are forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including, but not limited to; the effect that the reverse stock split may have on the price of the Company’s common stock; the ability or inability to maintain the listing of CDT's securities on Nasdaq; the ability to recognize the anticipated benefits of the business combination completed in September 2023, which may be affected by, among other things, competition; the ability of the combined company to grow and manage growth economically and hire and retain key employees; the risks that CDT's product candidates in development fail clinical trials or are not approved by the U.S. Food and Drug Administration or other applicable authorities on a timely basis or at all; changes in applicable laws or regulations; the possibility that CDT may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties identified in other filings made by CDT with the U.S. Securities and Exchange Commission. Moreover, CDT operates in a very competitive and rapidly changing environment. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond CDT's control, you should not rely on these forward-looking statements as predictions of future events. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and except as required by law, CDT assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. CDT gives no assurance that it will achieve its expectations.

Investors
CDT Equity Inc.
Info@cdtequity.com

FAQ

What did CDT (Nasdaq: CDT) purchase on October 17, 2025?

CDT bought 9.25648743 BTC for an aggregate $1,005,000 at an average of $108,301.75 per BTC.

How many Bitcoin does CDT hold after the October 17, 2025 acquisition?

After the transaction CDT holds 17.9090111 BTC in total.

How much did CDT spend per Bitcoin in the October 17, 2025 purchase?

The average acquisition price was $108,301.75 per BTC.

Why did CDT purchase additional Bitcoin on October 17, 2025?

CDT said the purchase advances its cryptocurrency treasury reserve strategy to diversify the balance sheet and pursue long-term shareholder value.

Does the October 17, 2025 purchase affect CDT’s liquidity?

The company deployed $1,005,000 to buy BTC, which reduces available cash reserves by that amount.

How does CDT describe its approach to Bitcoin acquisitions?

CDT described its approach as a disciplined, opportunistic treasury reserve program aligned with institutional adoption of digital assets.